GO:0045277 respiratory chain complex IV: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045277 (respiratory chain complex IV, cytochrome c oxidase) is the terminal enzyme of the mitochondrial respiratory chain that catalyzes the oxidation of reduced cytochrome c by dioxygen.
• The complex contains 13 polypeptide subunits in mammals, including the heme a and heme a3 copper centers that form the catalytic core.
• Complex IV is assembled through a series of maturation steps that require dedicated assembly factors and is often organized within larger respirasome supercomplexes.
• Loss or dysfunction of complex IV is linked to mitochondrial disease, neurodegeneration, osteoarthritis and metabolic disorders.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of complex IV subunit and assembly-factor function.
• Accurate assessment of complex IV activity relies on standardized enzymatic assays and structural methods such as cryo-electron tomography.
Description
Respiratory chain complex IV, also known as cytochrome c oxidase, is the terminal electron acceptor of the mitochondrial respiratory chain and is annotated in the Gene Ontology as GO:0045277 (respiratory chain complex IV). It catalyzes the oxidation of reduced cytochrome c by dioxygen, a reaction that consumes protons and contributes to the proton gradient used for ATP synthesis. Because it is the final step of the electron transport chain, complex IV is a focal point for understanding mitochondrial bioenergetics, cellular redox balance and the pathophysiology of mitochondrial disorders. Recent structural work has revealed how complex IV is embedded within the mitochondrial inner membrane and how it assembles into higher-order supercomplexes, often called respirasomes. These insights have been enabled by advances in cryo-electron tomography, single-particle cryo-EM and biochemical assays that resolve the composition and activity of the complex in situ. For researchers, GO:0045277 provides a precise framework to study the 13 polypeptide subunits, their assembly factors and the catalytic heme-copper centers that define this enzyme. The term is therefore central to investigations of oxidative phosphorylation, mitochondrial disease mechanisms and therapeutic strategies that target mitochondrial function.
respiratory chain complex IV At A Glance
| GO ID | GO:0045277 |
|---|---|
| GO term | respiratory chain complex IV |
| Ontology | cellular_component |
| Synonym | cytochrome c oxidase complex; electron transport complex IV |
| Major function | Catalyzes the oxidation of reduced cytochrome c by dioxygen (O2) as the terminal step of the respiratory chain |
| Subunit composition | Contains 13 polypeptide subunits in mammals, including cytochrome a and cytochrome a3 |
| Cofactors | Heme a, heme a3, copper centers (CuA and CuB) that form the catalytic site |
| Cellular location | Mitochondrial inner membrane, often organized within respirasome supercomplexes |
| Related disease examples | Mitochondrial disorders, osteoarthritis, neurodegeneration and metabolic dysfunction |
What Is GO:0045277?
GO:0045277 describes the respiratory chain complex IV, a part of the respiratory chain that contains the 13 polypeptide subunits of cytochrome c oxidase, including cytochrome a and cytochrome a3. It catalyzes the oxidation of reduced cytochrome c by dioxygen (O2). In practical terms, this ontology term captures the terminal oxidase of the mitochondrial electron transport chain, the enzyme that transfers electrons from cytochrome c to molecular oxygen and contributes to the proton motive force.
Why Is respiratory chain complex IV Important in Cell Biology?
Respiratory chain complex IV is essential for aerobic energy production and for maintaining cellular redox homeostasis, making GO:0045277 a key term for understanding mitochondrial physiology and disease. Because it is the terminal oxidase, its activity directly influences oxygen consumption, ATP synthesis and reactive oxygen species production, and its dysfunction has been implicated in a wide range of human pathologies including mitochondrial myopathies, neurodegeneration and osteoarthritis. Studying this complex also provides a paradigm for understanding how multi-subunit membrane protein complexes are assembled and regulated within the mitochondrial inner membrane.
• Complex IV is the terminal enzyme of the respiratory chain and is required for oxidative phosphorylation and ATP production.
• It contains 13 polypeptide subunits and multiple redox cofactors, making it a model for studying membrane protein assembly.
• Dysfunction of complex IV is associated with mitochondrial diseases and neurodegenerative conditions.
• Complex IV is often organized into respirasome supercomplexes that influence membrane architecture and respiratory efficiency.
• Targeting complex IV subunits such as COX4I2 can modulate disease progression in osteoarthritis models.
• Environmental toxins such as thorium can inhibit complex IV activity, highlighting its sensitivity to xenobiotics.
• Standardized enzymatic assays for complex IV are essential for diagnosing mitochondrial disorders.
• Reduced respirasome levels can be compensated in vivo, revealing plasticity of the respiratory chain.
• Complex IV assembly requires dedicated assembly factors and late maturation steps that are now structurally characterized.
• CRISPR-based models enable causal testing of complex IV gene variants in human cells and animal models.
What Happens During respiratory chain complex IV?
Electron transfer from cytochrome c to oxygen
In simple terms: Complex IV takes electrons from cytochrome c and hands them to oxygen, making water.
The catalytic core of complex IV accepts electrons from reduced cytochrome c at the CuA site and transfers them through heme a to the heme a3-CuB binuclear center, where dioxygen is reduced to water. This electron transfer is the terminal step of the respiratory chain and is coupled to proton pumping across the inner mitochondrial membrane.
Proton pumping and contribution to the proton motive force
In simple terms: As it reduces oxygen, complex IV also pumps protons to help store energy.
During turnover, complex IV consumes protons from the matrix and pumps additional protons across the inner membrane, contributing to the proton motive force that drives ATP synthesis. Structural studies of the respirasome have revealed how complex IV is positioned relative to complexes I, II and III to facilitate efficient electron transfer and proton translocation.
Assembly and maturation of complex IV
In simple terms: Complex IV is built step by step with the help of assembly factors.
The 13 subunits of mammalian complex IV are encoded by both mitochondrial and nuclear genomes and are assembled through a coordinated pathway that requires assembly factors for cofactor insertion and subunit stabilization. Recent structural work has defined late maturation steps within the human respirasome, showing how heme a and heme a3-CuB centers are inserted and how the complex reaches its mature form.
Supercomplex organization and membrane architecture
In simple terms: Complex IV often works together with other complexes in a larger assembly.
Complex IV can associate with complexes I, III and II to form supercomplexes, including the I-II-III2-IV2 arrangement that bends the mitochondrial membrane. In-cell architecture studies using cryo-electron tomography have shown that respiratory chain complexes are organized in situ in ways that may optimize electron transfer and membrane curvature.
Regulation by subunit isoforms and signaling
In simple terms: Cells can change how complex IV works by swapping subunits or modifying them.
Complex IV activity can be modulated by subunit isoform switching, such as the SIRT3-COX4I2 axis, which reprograms mitochondrial respiratory chain complexes in osteoarthritis. Post-translational modifications and assembly factor availability further regulate the amount and activity of complex IV in response to metabolic cues.
Key Genes Involved in GO:0045277 respiratory chain complex IV
The following genes encode subunits, assembly factors and regulatory proteins that define the composition and function of respiratory chain complex IV (GO:0045277).
| Gene | Major Role | Research Relevance |
|---|---|---|
| COX1 (MT-CO1) | Mitochondrially encoded catalytic subunit of complex IV | Core catalytic subunit; mutations cause mitochondrial disease |
| COX2 (MT-CO2) | Mitochondrially encoded subunit containing CuA site | Electron entry site; target for functional studies |
| COX3 (MT-CO3) | Mitochondrially encoded subunit involved in proton pumping | Assembly and proton translocation studies |
| COX4I1 | Nuclear-encoded regulatory subunit | Ubiquitous isoform; regulates complex IV activity |
| COX4I2 | Nuclear-encoded isoform regulated by SIRT3 | Target in osteoarthritis and metabolic reprogramming |
| COX5A | Nuclear-encoded subunit | Assembly and stability of complex IV |
| COX5B | Nuclear-encoded subunit | Isoform-specific regulation of complex IV |
| COX6A1 | Nuclear-encoded subunit | Mutations linked to mitochondrial disorders |
| COX6B1 | Nuclear-encoded subunit | Assembly factor interactions |
| COX7A2 | Nuclear-encoded subunit | Regulation of complex IV in different tissues |
| COX8A | Nuclear-encoded subunit | Subunit required for holoenzyme stability |
| SURF1 | Assembly factor for complex IV | Mutations cause Leigh syndrome; assembly studies |
| SCO1 | Copper chaperone for CuA site | Cofactor insertion and assembly |
| SCO2 | Copper chaperone for CuB site | Cofactor insertion and assembly |
| COX10 | Heme a biosynthesis and insertion | Assembly factor; mutations cause mitochondrial disease |
| COX15 | Heme a biosynthesis | Assembly factor; target for functional studies |
| SIRT3 | Deacetylase regulating COX4I2 | Regulates complex IV in osteoarthritis |
How Is respiratory chain complex IV Regulated?
Respiratory chain complex IV is regulated at multiple levels, including transcriptional control of nuclear-encoded subunits, mitochondrial gene expression, assembly factor availability and post-translational modifications. The SIRT3-COX4I2 axis exemplifies how deacetylation and isoform switching can reprogram complex IV activity in response to metabolic stress, as shown in osteoarthritis models. In addition, the assembly of complex IV into respirasomes is influenced by the availability of other respiratory chain complexes and by membrane lipid composition, as revealed by structural studies of supercomplexes. Reduced respirasome levels can be compensated in vivo, indicating that cells can adjust respiratory chain capacity through regulatory mechanisms that remain an active area of research.
respiratory chain complex IV and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SURF1 | Leigh syndrome with complex IV deficiency | Knockout and knock-in iPSC-derived neurons |
| COX4I2 | Osteoarthritis progression | Overexpression and knockout chondrocytes |
| SCO2 | Mitochondrial myopathy and cardiomyopathy | Point-mutation knock-in cell models |
| COX10 | Mitochondrial disease with heme a defect | Knockout and rescue models |
| MT-CO1 | Mitochondrial myopathy and deafness | Cytoplasmic hybrid (cybrid) models |
Mitochondrial disease and complex IV deficiency
Mutations in complex IV subunits or assembly factors such as SURF1, SCO1, SCO2, COX10 and COX15 cause mitochondrial disorders that often present as Leigh syndrome or severe encephalomyopathy. Enzymatic assessment of complex IV activity in tissues and cultured cells is a standard diagnostic approach for these conditions.
Osteoarthritis and metabolic reprogramming
Reprogramming of the mitochondrial respiratory chain complex by targeting the SIRT3-COX4I2 axis attenuates osteoarthritis progression, demonstrating that complex IV regulation is causally linked to joint degeneration. This highlights complex IV as a potential therapeutic target in musculoskeletal disease.
Neurodegeneration and respiratory chain dysfunction
Preserved respiratory chain capacity in mice with profoundly reduced respirasome levels suggests that neurons can tolerate substantial changes in complex IV organization, but chronic dysfunction is associated with neurodegenerative phenotypes. Structural insights into complex IV maturation within the respirasome provide a framework for understanding how assembly defects may contribute to neurodegeneration.
Toxicology and environmental inhibition
Thorium inhibits human respiratory chain complex IV (cytochrome c oxidase), illustrating that environmental exposures can directly impair terminal oxidase activity. Such inhibition can disrupt oxidative phosphorylation and has implications for metal toxicity and occupational health.
From respiratory chain complex IV-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a complex IV subunit impair respiration? | CRISPR knockout in HEK293 or HeLa cells |
| Does a patient variant cause complex IV deficiency? | Point-mutation knock-in in iPSCs |
| Can a specific isoform rescue complex IV activity? | Knock-in of tagged or isoform-specific alleles |
| How does complex IV assemble in real time? | Tagged knock-in with fluorescent or affinity tags |
| Does overexpression of COX4I2 protect against disease? | Overexpression in chondrocytes or mouse models |
| How do supercomplexes organize in situ? | Cryo-electron tomography of wild-type and mutant cells |
How to Study the respiratory chain complex IV Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cytochrome c oxidase assay | Complex IV enzymatic activity | Diagnosis of mitochondrial disease |
| Blue-native PAGE | Supercomplex and complex IV assembly | Assembly factor studies |
| Cryo-electron tomography | In-cell architecture of respiratory chain | Supercomplex organization |
| Single-particle cryo-EM | High-resolution structure of complex IV | Maturation and cofactor insertion |
| Immunoblotting | Subunit protein levels | Isoform switching and knockout validation |
| Mass spectrometry | Subunit composition and modifications | Proteomic profiling |
| Seahorse respirometry | Oxygen consumption rate | Functional validation of CRISPR models |
| Mitochondrial membrane potential dyes | Proton motive force | Assessment of complex IV function |
Enzymatic activity assays for complex IV
Standardized spectrophotometric assays measure cytochrome c oxidase activity in tissues and cultured cells, providing a direct readout of complex IV function. These protocols are essential for diagnosing mitochondrial disorders and for validating CRISPR models.
Structural biology and in-cell architecture
Cryo-electron tomography and single-particle cryo-EM have revealed the in-cell architecture of the mitochondrial respiratory chain and the structural basis of complex IV maturation within the human respirasome. These methods allow researchers to visualize supercomplex organization and membrane bending.
Biochemical and proteomic analysis of subunits
Blue-native PAGE, immunoblotting and mass spectrometry can resolve the subunit composition of complex IV and its assembly intermediates. Proteomic approaches are useful for quantifying isoform switching, such as COX4I2 versus COX4I1, in response to metabolic cues.
Genetic and pharmacological perturbation
CRISPR knockout, point-mutation knock-in and overexpression models enable causal testing of complex IV gene function. Pharmacological inhibitors and environmental toxins such as thorium can be used to probe catalytic activity and cellular responses.
How CRISPR Can Be Used to Study GO:0045277 respiratory chain complex IV
Knockout
CRISPR knockout of nuclear-encoded complex IV subunits or assembly factors such as SURF1, SCO1, SCO2, COX10 and COX15 allows researchers to determine whether these genes are required for complex IV assembly and respiration. Knockout models can be validated by enzymatic assays and blue-native PAGE.
Point Mutation
Point-mutation knock-in of patient variants in genes such as SCO2 or MT-CO1 enables causal testing of whether a specific amino acid change impairs complex IV activity. These models are particularly valuable for distinguishing pathogenic variants from benign polymorphisms.
Knock-in
Tagged knock-in of complex IV subunits, for example with fluorescent or affinity tags, facilitates live-cell imaging and biochemical purification of the complex. Knock-in of isoform-specific alleles such as COX4I2 can be used to study isoform-specific functions.
Overexpression
Overexpression of complex IV subunits or regulatory proteins such as COX4I2 can test whether increased complex IV activity protects against disease phenotypes, as shown in osteoarthritis models. Overexpression models are also useful for structure-function studies of assembly factors.
How EDITGENE Supports respiratory chain complex IV Research
Researchers studying respiratory chain complex IV-related genes often need to determine whether a candidate gene is causally involved in complex IV assembly, activity or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models that answer these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for respiratory chain complex IV research.
Frequently Asked Questions About respiratory chain complex IV
What is GO:0045277 respiratory chain complex IV?
GO:0045277 is the Gene Ontology term for respiratory chain complex IV, also known as cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain that catalyzes the oxidation of reduced cytochrome c by dioxygen.
What genes are involved in respiratory chain complex IV?
Key genes include the mitochondrial-encoded COX1, COX2 and COX3, nuclear-encoded subunits such as COX4I1, COX4I2, COX5A and COX6A1, and assembly factors such as SURF1, SCO1, SCO2, COX10 and COX15.
What is the function of cytochrome c oxidase complex?
It transfers electrons from reduced cytochrome c to molecular oxygen, reducing oxygen to water and contributing to the proton motive force used for ATP synthesis.
How is respiratory chain complex IV assembled?
It is assembled from 13 subunits encoded by mitochondrial and nuclear genomes through a coordinated pathway requiring assembly factors for cofactor insertion and subunit stabilization.
What diseases are linked to complex IV dysfunction?
Complex IV dysfunction is linked to mitochondrial diseases such as Leigh syndrome, neurodegeneration, osteoarthritis and metabolic disorders.
How do you measure respiratory chain complex IV activity?
Cytochrome c oxidase activity is measured using standardized spectrophotometric assays on tissues or cultured cells, often complemented by blue-native PAGE and respirometry.
Can CRISPR be used to study respiratory chain complex IV?
Yes, CRISPR knockout, point-mutation knock-in, tagged knock-in and overexpression models are widely used to study complex IV subunit and assembly factor function.
What is the structure of respiratory chain complex IV?
It is a multi-subunit membrane protein complex containing heme a, heme a3 and copper centers, and it can assemble into supercomplexes such as the I-II-III2-IV2 respirasome.
Is respiratory chain complex IV the same as cytochrome c oxidase?
Yes, respiratory chain complex IV is synonymous with cytochrome c oxidase complex and electron transport complex IV.
How does SIRT3 regulate complex IV?
SIRT3 deacetylates and regulates COX4I2, reprogramming mitochondrial respiratory chain complexes and attenuating osteoarthritis progression in models.
Conclusion
Respiratory chain complex IV (GO:0045277) is the terminal oxidase of the mitochondrial respiratory chain and a central node in oxidative phosphorylation, cellular redox balance and mitochondrial disease. Advances in structural biology, in-cell imaging and CRISPR-based genetics have clarified its subunit composition, assembly pathway and supercomplex organization. Dysfunction of complex IV is implicated in mitochondrial disorders, neurodegeneration, osteoarthritis and toxicological responses, making it a high-value target for both mechanistic and translational research. By combining precise CRISPR models with rigorous biochemical and structural methods, researchers can causally link complex IV genes to cellular and organismal phenotypes.
References
- 1. Waltz F et al.. 2025. In-cell architecture of the mitochondrial respiratory chain.. Science 387(6740):1296-1301 PMID: 40112058
- 2. Zhang Y et al.. 2023. Reprogramming of Mitochondrial Respiratory Chain Complex by Targeting SIRT3-COX4I2 Axis Attenuates Osteoarthritis Progression.. Adv Sci (Weinh) 10(10):e2206144 PMID: 36683245
- 3. Yu L et al.. 2022. Thorium inhibits human respiratory chain complex IV (cytochrome c oxidase).. J Hazard Mater 424(Pt B):127546 PMID: 34879532
- 4. Spinazzi M et al.. 2012. Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells.. Nat Protoc 7(6):1235-46 PMID: 22653162
- 5. Kadenbach B et al.. 1991. Respiratory chain proteins.. Rev Neurol (Paris) 147(6-7):436-42 PMID: 1660179
- 6. Milenkovic D et al.. 2023. Preserved respiratory chain capacity and physiology in mice with profoundly reduced levels of mitochondrial respirasomes.. Cell Metab 35(10):1799-1813.e7 PMID: 37633273
- 7. Nguyen MD et al.. 2026. Structural basis for late maturation steps of mitochondrial respiratory chain complex IV within the human respirasome.. Nat Commun 17(1):1550 PMID: 41519940
- 8. Mühleip A et al.. 2023. Structural basis of mitochondrial membrane bending by the I-II-III(2)-IV(2) supercomplex.. Nature 615(7954):934-938 PMID: 36949187
